Interplay between COVID-19 and Secukinumab treatment in Spondylarthritis patients during the omicron surge: a retrospective cohort study
The objective of this retrospective cohort study was to assess the relationship between Corona Disease 2019 (COVID-19) and Secukinumab treatment in patients with Spondylarthritis (SpA) in China during the omicron surge. Researchers retrieved 1018 medical records of Secukinumab-treated patients between January 2020 and January 2023 from the West China Hospital of Sichuan University. Out of these, 190 SpA patients from the rheumatology clinic were selected for the study. Guided phone questionnaires were administered by research staff to collect baseline characteristics, SpA disease status, and COVID-19 clinical outcomes. Coh...
Source: Autoimmunity - December 14, 2023 Category: Allergy & Immunology Authors: Tong Wu Yanhong Li Deying Huang Yinlan Wu Xiuping Liang Lu Cheng Zehui Liao Fang Xu Ye Chen Jing Zhao Zijing Xia Chunyu Tan Yi Liu Martin Herrmann Source Type: research
